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Abstract
This study analyzes the health impacts of particulate matter 2.5 (PM 2.5), a common anthropogenic
pollutant resulting from vehicles, manufacturing, and wood burning. PM 2.5 is an emission of particular
concern given its small size of roughly 2.5 micrometers, allowing it to stay in the atmosphere for up to 10
days and penetrate the deepest area of the lungs, the alveoli. This penetration can lead to adverse
respiratory and cardiovascular health outcomes, and ultimately lead to an increased mortality rate. This
study utilizes data from 1,885 counties in the U.S. between 2001 and 2017, and included health outcome,
PM2.5 , and demographic data. The results from two-way fixed effects regression models show that an
increase in PM2.5 does lead to an increase in the respiratory mortality rate, and that this effect is largely
seen in counties with a below average poverty rate and an above average minority population. These
results suggest that racial and economic inequalities exist for both healthcare access and proximity to
pollution sources for lower income and diverse counties underlining the need for policies to address this
public health concern.

Introduction
As the world moves deeper into the 21st century, the impacts of climate change have
become more pronounced, while the window to take climate action quickly has shortened.
Traditional arguments for climate action have focused on the financial costs of inaction,
including the impacts of increasingly severe and frequent natural whether events on
infrastructure, and the toll on crop production resulting in food scarcity. Arguments for taking
climate action also focus on humanity’s impact on the environment, such as disappearing reefs,
plastic waste in the oceans, and the extinction of animal species. While these effects are
important, an area of impact more complex to evaluate are the health costs associated with the
various threats that climate change poses. The effects of climate change on human health are
significant, with the impacts resulting in decreased life expectancy, decreased quality of life, and
increased healthcare spending. These impacts are more difficult to quantify, as there a variety of
effects in both the short term and long term to consider. The impacts of anthropogenic emissions,
the principal driver of climate change, have a wide variety of effects, from being a leading
contributor to rising global temperatures, to decreasing air quality (Redlin & Gries 2021).
An emission source of particular concern is particulate matter 2.5 (PM 2.5) as it has an
impact on both respiratory and cardiovascular functionality and can lead to premature deaths
particularly among at-risk populations (Giannadaki et al 2016, Correia et al 2016, Ostro et al
2006). PM2.5 is a particle or droplet produced from anthropogenic and natural sources with a
diameter equal to or less than 2.5 micrometers. Anthropogenic sources of PM 2.5 are vehicle
emissions, industrial manufacturing, and burning of leaves and wood (McDuffie et al 2021).
Studying the effects of PM2.5 on health outcomes is of significant relevance given its previously
studied negative effects, and abundance in populations centers making it strong candidate to raise

awareness of the impacts of human caused emissions, as well as motivate further policy action.
This study attempts to understand the association between changes in PM 2.5 yearly exposure and
respiratory, cardiovascular, and all-cause mortality, as well as which demographic groups are
more at risk. The study analyzes data over a 15-year period for 1,740 counties.

Prior Studies & Research
Prior studies have investigated the medical health risks, pollution sources, spatial
distribution, and measured health effects of PM 2.5. The following section covers what PM 2.5
pollution entails, its sources, the relevant medical literature, and lastly an in-depth overview of
three previous studies which highlight the main methods used in analyzing the health effect of
PM2.5. Particulate Matter (PM) is a mixture of fine particles and droplets with a diameter of less
than 10 microns or roughly one-seventh the width of human hair (Lim et al 2012). Some PM can
be visible when in large amounts, such as dust, smoke, and soot, while fine, unconcentrated PM
must be viewed through an electron microscope (Close 2021). PM is broken into two main
categories, PM10 and PM2.5. PM10 are droplets and particles with a diameter between 2.5 and 10
microns and have been found to have a variety of health effects ranging from ischemic heart
disease (heart problems from narrowed arteries) to myocardial infractions (Du et al 2016). PM 2.5
are droplets and particles with a diameter of less than 2.5 microns and have been found to cause
significant short and long term respiratory and cardiovascular health effects (Lim et al 2012).
This current study, which highlights the effects of human-caused climate change on health,
focuses on the effects of PM2.5 for two reasons: its smaller size allows for further penetration into
the lungs, and it has longer atmospheric circulation periods; both increase the magnitude of the
health effects of PM2.5 relative to PM10.

Direct sources of PM2.5 are forest fires, waste burning, windblow suspended dust particles
from dry regions, and incomplete vehicle combustion (McDuffie et al 2006). Indirect PM 2.5 is the
result of chemical reactions in the atmosphere between gaseous precursor pollutants which are
emitted from combustion processes in vehicles, energy generation, industrial manufacturing, as
well as non-combustion emissions from solvents and fertilizer applications (McDuffie et al
2006). The most common precursor pollutants for PM 2.5 are sulfur dioxide (SO2), nitrogen
oxides (NOx), volatile organic compounds, and ammonia (NH3) (Mathias & Wayland 2019).
After the precursor pollutants are in the atmosphere, the formation of PM 2.5 is highly irregular
with factors such as total pollutant mass, atmospheric conditions, and source dominance
effecting the amount of PM2.5 formed through chemical processes (Mathias & Wayland 2019).
The composition of PM2.5 is a complex mixture of organic and inorganic compounds
making up the droplets and particles while atmospheric conditions heavily influence the
concentration and geographical location of PM 2.5. Broadly, particulate matter consists of heavy
metals, carbonaceous components, and water-soluble ions. Water-soluble inorganic ion
components have been found to account for roughly 50 percent of PM 2.5 (Begam et al 2016). A
study looking at the components of water-soluble aerosol particles in Hefei, China found that the
most common water-soluble ions found in PM 2.5 are Sulfate (S042-), Nitrate (N03-), Ammonium
(NH4+), and Calcium (Ca2+) ions (Deng at al 2016). Sulfate pollution has been traced to industrial
emissions, while Nitrate emissions were associated with heavy traffic due to their presence in
vehicle exhaust (Deng at al 2016). Calcium ions in the atmosphere usually arises from soil
particulates being lifted into the air through construction, with the study finding the highest
concentrations near residential construction sites (Deng at al 2016). In different geographical
locations the concentration of calcium ions in the atmosphere may be caused by environmental

factors such as large wind events (Close 2021). Ammonium concentrations originate from
biomass burning and lower in economically developed areas (Deng at al 2016). The above
inorganic water-soluble ions pose health risks because their ability to easily penetrate the lungs
barrier to the alveolar region, altering gene expression within the lungs, while exposure to
Sulfate and Nitrate ions specifically was found to induce the expression of genes corresponding
with tumorigenesis (Park et al 2022).
Heavy metals are also present in PM2.5 emissions, allowing for access into the human
body through the respiratory system, skin, or ingestion. Nickel (Ni), Cadmium (Cd), Chromium
(Cr), are all class I carcinogenic contaminants and are present in PM 2.5 (Liu et al 2017). Also
present in PM2.5 are Lead (Pb), a class II carcinogenic, as well as Copper (Cu), Zink (Zn), and
Manganese (Mn) (Liu et al 2017). The presence of on these heavy metals in PM 2.5, given its
ability to reach the lungs alveoli and penetrate the lungs barrier, may pose not only increased risk
of cancer from the carcinogenic metals, but also cause respiratory illness (Peled R 2011). A
study by Liu et al. investigated the concentration and sources of heavy metals in PM 2.5 during
heavy haze periods in Taiyuan China and found the presence of all the above metals (Liu et al
2017). The sources of Pb, Zn, Cu, Ni, and Cr in PM 2.5 were from coal combustion, Mn and Cd
were sourced to road dust and soil, Ni, Cd, and Cu were traced to industrial emission while
traffic emissions were responsible for Zn and Cu (Liu et al 2017). The presence of these heavy
metals in PM2.5 further illustrates the potential health impacts it may have on heavily exposed
individuals.
The last major component of PM2.5 are carbonaceous components which include organic
carbon and elemental carbon. Elemental carbon is a primary pollutant formed during combustion
processes while organic carbon is formed from a mixture of compounds emitted from primary

sources before undergoing a secondary formation in the atmosphere (Seinfeld & Pandis 1998). A
study in Helsinki Finland found that the main sources of carbonaceous components were
biomass combustion, traffic, and long-range transport (Saarikoski et al 2008). The presence of
carbonaceous components has been linked to reduced lung function, even among young and
healthy adults (Huang et al 2019). Wholistically, the composition of PM 2.5, its variety of sources,
along with its small size presents a unique challenge to public health. The following section of
the literature review will analyze three studies which are representative of previous methods used
to evaluate the health impacts of PM2.5.
A study by Giannadaki et al. published in Environmental Health in 2016 looked at the
health benefits of implementing PM2.5 regulations which set the yearly standard at 12 μg/m3, the
current standard in the U.S. (Giannadaki et al 2016). This study employed a relative risk factor
function using PM2.5 data from the EMAC global atmospheric chemistry general circulation
model to attribute the increased risk of mortality from PM 2.5 concentrations. The use of this
model allowed for the study to evaluate premature mortality rates at the global level. For the
population above 30 years old the study evaluated mortality rates for Cerebrovascular Disease,
Chronic Obstructive Pulmonary Disease, Ischemic Heart Disease, and lung cancer within the
model. The premature mortality rate due to acute lower respiratory infection was used to analyze
the effects of PM2.5 on children under the age of 5. Furthermore, the study conducted sensitivity
analysis to estimate the additional or reduced premature mortality from the above causes when
the PM2.5 concentration is held at various regulatory levels, including the U.S. limit of 12 μg/m3,
the WHO recommendation of 10 μg/m3 and the current EU standard of 25 μg/m3.
The results of the study showed that in 2010 there were an estimated 3.15 million
premature deaths due to PM2.5 exposure worldwide. The leading causes of premature death from

PM2.5 were Cerebrovascular Disease, estimated to cause 1.31 million premature deaths, ischemic
heart disease, 1.08 million premature deaths, and Chronic Obstructive Pulmonary Disease with
374,000 premature deaths. The use of the EMAC global atmospheric circulation model allowed
for the exposure response model used in the study to evaluate the premature mortality levels for
each country. The country with the most premature deaths was China with 1.33 million, followed
by India with 575,000. The E.U. was found to have 173,000 premature deaths, with Germany
contributing the largest portion with 34,000 respectively, the U.S. was the 7 th highest country on
the list with an estimated 52,000 premature deaths in 2010. The results of the study were in line
with previous studies using similar variations of the integrated health risk function including
Apte et al. with an estimated 3.24 million premature deaths, Lelieveld et al. with 2.2 million,
and a 2010 GBD study which estimated 3.22 million premature deaths (Apte et al 2015,
Lelieveld et al 2013, Lim et al 2012). The larger difference with the Lelieveld et al. study can
likely be attributed to measuring only anthropogenic sources of PM 2.5 while this study the looked
at anthropogenic and natural sources of PM 2.5 .
Using the results from the baseline model, the study then conducted sensitivity analysis
where the PM2.5 levels were set at various regulatory limits. The first variation of the model was
holding PM2.5 levels at the current (2010) regulatory limits for each country. The model showed
an expected 9% decrease in global premature mortality from PM 2.5 with the main reduction
coming from China with 16% fewer deaths, while the U.S. would be expected to have 4% fewer
deaths. The second sensitivity analysis applied the E.U. regulatory limit of 25 μg/m3 to the model
and found that there would be a 17% reduction in premature mortality compared to the 2010
PM2.5 concentration base model. This variation was found to have no effects on premature
mortality in the E.U. as most areas were already below this limit, while in China there would be

a 31% reduction in premature mortality or about 417,000 premature deaths avoided. The final
sensitivity model used the U.S. PM2.5 regulatory limit of 12 μg/m3 and the results showed an
expected 46% reduction in global premature mortality. The U.S. would be expected to see a 4%
reduction in premature mortality or roughly 3,000 fewer deaths, while the E.U. would see a 20%
reduction or nearly 138,000 premature deaths. Implementing the U.S. regulatory limit in China
would reduce premature mortality by nearly 70% according to the model. In some areas the
study noted that adhering to the U.S. limit would not be possible, as areas in Northern Africa,
and Middle East and Southeast Asia experience a high amount of non-anthropogenic PM 2.5. The
main conclusion of the study was that the strong response in premature mortality rate due to a
decrease in PM2.5 levels, was largely a result of the high number of populated areas with
increased levels of pollution which would see heightened benefits from a reduction on PM 2.5, and
therefore, the implantation of the U.S. regulatory standard, in geographic areas where natural
causes do not make it impossible, would provide remarkable health benefits.
A study by Correia et al. looked at the impacts of PM 2.5 on life expectancy in the United
States (Correia et al 2013). This study is relevant to the work presented below, given its use of
county level data within the U.S. The motivation for the study was to evaluate how the decrease
in the level of PM2.5 between 2000 and 2007 had brought about an improvement in life
expectancy. Three different datasets were used for the regression analysis, and multiple
variations of the model were run to perform stratified and weighted analysis. The main dataset
used information from 545 U.S. counties with PM 2.5 data for 2000 and 2007, and the study
differed from previous studies by including counties in non-metropolitan areas. PM 2.5 data was
from the EPA’s Air Quality System. Daily PM2.5 values for each monitor in a county were used
and then averaged to create a daily average PM 2.5 value for the county; the daily average levels

for each county were then averaged across each day to arrive at a yearly PM 2.5 average for each
county in the dataset. Additional variables were also included only if available for each county in
the dataset for both 2000 and 2007. Life expectancy was the dependent variable in the model,
and per capita income, population size, percentage of high school graduates, and percentage of
minority races were all included as covariates in the model. Additionally, effects due to smoking
prevalence were measured using age standardized death rates for lung cancer and chronic
obstructive pulmonary disease, because there was not smoking data available for each county in
the dataset. The socioeconomic and demographic variables were from the U.S. Censes and
American Community Survey, except for per capita income which came from the Bureau of
Labor Statistics. Life expectancy was calculated for each county using a mixed effects spatial
Poisson model applied to mortality data from the National Center for Health Statistics.
Correia et al. ran multiple specifications of their model, first regressing life expectancy
against PM2.5 levels on data from 2000 and 2007 for all counties. Next, the change in life
expectancy between 2000 and 2007 was regressed against the change in PM 2.5 over the same
period. This regression model was then run on subsets of the data based on percentage of
population in urban settings in 2000, population density in 2000, land area in 2000, PM2.5 level
in 2000, and average temperature. Sensitivity analysis was also performed using model weighted
by population, population density, and inverse land area. There were also two additional datasets
used, which were for longer periods of time on a smaller portion of higher population counties
for comparative analysis with previous research.
The first regression looking at the impact of PM 2.5 on life expectancy for each county in
2000 and 2007 provided no significant results, suggesting that the baseline level of PM 2.5 had no
impact on life expectancy. The regression evaluating the impact of the change in PM 2.5 levels on

the change in life expectancy, when holding for socioeconomic and demographic variables,
suggested that a 10 μg/m3 reduction in PM2.5 resulted in a mean increase in life expectancy of
0.35 years. The regression ran on the subset of higher population density counties (greater than
200 people per square mile) found that a 10 μg/m3 reduction in PM2.5 levels led to a 0.72-year
increase in life expectancy at a 95% confidence level, while the PM 2.5 variable in the regression
ran on lower population density counties (less than 200 people per square mile) was
insignificant. A similar result was also discovered when the model was run on subsets of the data
where over 90% of the population lived in urban setting, and less than 90% of the county lived in
urban settings.
Ultimately, the results showing that a reduction in PM 2.5 levels were associated with an
increase in life expectancy of 0.35 years on average. The benefits were greatest in counties with
a higher concentration of the population in urban settings. The authors of the study presented
multiple explanations for this greater improvement. First, the components making up PM 2.5 from
urban pollutions sources may be more harmful than those in rural areas, making their reduction
more beneficial to health outcomes. Second, urban areas may have seen greater advancements in
medical care, and higher insurance rates, further reducing the health impacts of PM 2.5 and
therefore increasing life expectancy. The results of this study represent a significant
improvement upon previous studies because of the large dataset used to analyze the effects, as
well as the simpler regression analysis chosen compared to the spatial variation and health risks
models used in prior studies. A potential issue with the study’s results is not capturing the trends
in the years between 200 and 2007, which could have further strengthened the study’s results by
allowing for the inclusion of county-level fixed effects to control for other unmeasured county
characteristics which may be correlated with both mortality and PM 2.5. Furthermore, the study

only evaluated the impacts of PM2.5 on all-cause life expectancy, while analysis of the effect of
PM2.5 on specific health conditions may be useful to further evaluate its impacts.
The last study examined in this literature review is by Ostro et al.; which analyzed the
effects of PM2.5 on mortality in nine California counties (Ostro et al 2006). The study looked
specifically at the relationship between PM2.5 levels and daily mortality between 1999 and 2002.
All-cause mortality was the main dependent variable; however, subcategories were also
explored, including respiratory, cardiovascular, ischemic heart disease, and diabetes. The
mortality data came from the California Department of Health Services and was combined to
form an all-cause total mortality variable and separated into subcategories according to WHO
death classifications. The data was also separated into subpopulations for further analysis,
including age greater than 65, male vs. female, and race/ethnicity. The pollutant data for PM 2.5
was from the EPA’s Aerometric Information Retrieval System. For counties with multiple
monitoring stations, the average across the stations was calculated, and missing data from
monitors was calculated using the same process as Wong et al. The study also accounted for
meteorological effects, including temperature and humidity, collected from weather stations in
each county. The end dataset was comprised of 1,461 days of time series data.
The method of analysis used by Ostro et al. was a Poisson regression for each county
before a meta-analysis was performed using a random effects model in Stata. For the individualcounty Poisson models, a penalized spline regression was used to account for variation resulting
from the change in time, and the PM2.5 levels as well as two-day average of PM2.5 levels were
lagged by one day.
The main results from the study showed that there was a relation between PM 2.5 and allcause mortality, as well as cardiovascular, respiratory and elderly mortality. The study found that

a 10 μg/m3 increase in PM2.5 resulted in a 0.6% increase in all-cause and cardiovascular
mortality. The results for all-cause mortality were lower than previous studies which the authors
believed was a result of measurement error due to the low level of monitors, the composition of
PM2.5 in California which may be less toxic, and the California population being less susceptible
to health impacts due to better diets and higher levels of exercise. For respiratory mortality a 10
μg/m3 increase in PM2.5 levels was found to increase the mortality rate by 2.2%. The last main
finding was that diabetics and individuals without a highschool education may be more at risk
from PM2.5 exposure in comparison to other sub-populations. A 10 μg/m3 increase in PM2.5 was
found to increase the mortality rate due to diabetes by 2.4%, much higher than other studies,
while non-high school graduates saw a 0.9% increase in mortality rate for a 10 μg/m3 increase
while those with a high school education saw only a 0.45% increase in mortality. Ultimately the
results of the study are in line with prior research, including those highlighted above, showing
that elevated levels of PM2.5 in the atmosphere have a negative impact on both specific health
outcomes (Ostro et al 2006, Giannadaki 2019), and life expectancy (Correia et al 2013).
This analysis presented below attempts to expand upon these previous studies by
incorporating various aspects of each while using an expanded dataset which includes both more
U.S. counties and more recent observations, allowing for an updated view on the health impacts
of PM2.5. Like Ostro et al., this study will evaluate the impacts of PM 2.5 exposure on specific
health outcomes, particularly looking at the effects on respiratory, cardiovascular, and all-cause
mortality rates. While that study only used data over a four-year period from 1999 until 2002,
this study evaluates the effects on a national level over a longer period, with 1,885 counties and
17 years of data used for the regression model. This breadth of county-level data is similar to the
county-level data used in Correia et al.; however, due to new reporting measures from the EPA, a

larger sample of counties can be included in the analyses presented here. Similarly, this paper
will investigate differential effects on areas with larger minority populations higher poverty to
further understand how these demographics are particularly affected by PM 2.5 emissions. The use
of time-series data in this study will also help address a potential weakness in Correia et al.’s
analysis, which only used data from 2000 and 2007 to, in turn, examine the changes in PM 2.5 and
life expectancy between the two time periods in the regression models. The authors addressed
how this weakness may have left out potential factors resulting from the change in time in the
regression model. Furthermore, the expanded dataset used here will provide a broader view on
PM2.5’s effects on across the U.S., as smaller counties with previously unavailable PM 2.5
estimates are now able to be included, as previous studies largely focused on larger counties as
they were more likely to have PM 2.5 monitoring stations. This study will also produce predicted
mortality rates to better interpret how different PM 2.5 concentrations effect mortality; this is
similar to the approach of producing predicted mortality rates at various regulatory levels
investigated by Giannadaki et al. By combining the various strengths of previous studies with
new and more expansive data, this study aims to further understand the effects of PM 2.5 on
mortality rates for the most-relevant health conditions and how these effects differ among
marginalized demographic groups, as well as evaluate the potential economic cost, measured by
the value of a statistical life, with the goal of expanding the available literature surrounding the
health effects and cost of PM2.5 emissions.

Data & Methodology
To analyze the effects of PM2.5 on health outcomes, a two-way fixed effect regression
model was used with panel data for the years 2001 through 2017, and 1,736 counties in the U.S.;
one “fixed effect” accounts for time-invariant, unmeasured characteristics across counties, while

the other “fixed effect” accounts for national, nonlinear time trends. The key independent
variable is average yearly PM2.5 levels and the key dependent variable is respiratory mortality
rates. Secondary analyses examined cardiovascular mortality rates and all-cause mortality rates.
Additionally, differential effects for minority populations and above-average poverty populations
were explored by examining smaller subsets of counties.
Data for the regression analysis was obtained from Health Resources and Services
Administration’s Area Health Resource File (AHRF), the Environmental Protection Agency
(EPA), the Census Bureau’s Small Area Income and Poverty Estimates (SAIPE), the Bureau of
Labor Statistics (BLS), the Center for Disease Control’s (CDC) National Center of Health
Statistics (NCHS). Regarding the outcomes, data for a county’s lower respiratory mortality rate
and cardiovascular mortality rate were obtained from the AHRF, though the numbers were
measured by the NCHS. The all-cause mortality rate was obtained from the AHRF, though the
numbers were measured by the U.S. Census Bureau. Regarding the key independent variable, the
yearly county-level average PM2.5 levels come from the EPA. Regarding the county-level
demographic control variables, the AHRF data also provide the percentage of the population
which was nonwhite, a county’s total population, and the percent of the population over the age
of 65. Poverty rates for counties were obtained from the SAIPE, while county unemployment
rates were from the BLS.
Measurements for mortality causes varied by federal guidelines. All-cause mortality rate
was measured in the annual number of deaths per 100 individuals, while respiratory mortality
rate was measured as the three-year average per 10,000 people. Averaging over three years is
used by NCHS to account for imprecision in one-year averages given the lower incidence rate of
chronic lower respiratory disease mortality. Additionally, given a change in CDC’s guidelines

announced in 2007 and implemented in 2010, NCHS stopped reporting deaths for a specific
mortality cause and time period if there were 10 or fewer deaths in a county. This affected the
data analysis presented here, as many smaller counties which had observable respiratory
mortality rates in the first seven years of the data were then unobservable after 2010. To account
for this change in reporting, the counties used in these analyses were limited to only those
counties which had a reportable respiratory mortality rate for all 18 years of sample data. NCHS
reporting of cardiovascular disease mortality rates experience similar reporting limitations due to
CDC guidelines. While cardiovascular disease mortality has a higher incidence rate than chronic
lower respiratory disease mortality, it is unobservable for more counties with 1,190 missing
values in the final dataset. The reason for this higher rate of missing data is a result of
cardiovascular mortality being comprised from three categories: ischemic heart diseases,
cerebrovascular diseases, and “other” cardiovascular diseases; each of these categories must have
more than 10 deaths a year in a county for the overall cardiovascular disease rate to be present in
the AHRF data.
Data for PM2.5 levels in a county for each year was obtained from the CDC’s National
Environmental Public Health Tracking Network, with measurements of PM 2.5 provided by the
EPA in micrograms per cubic meter (μg/m3). The PM2.5 data was obtained from the Air Quality
System (AQS) for counties with measurement stations, and the Downscaler model was used to
create predicted values for counties and days without measurements from monitoring stations.
The Downscaler model generates predicted PM 2.5 levels from a combination of AQS data and the
Community Multiscale Air Quality model-predicted concentration values to create a spatial
model. A study by Wang et al found that the Downscaler model produced an R 2 of 72%
suggesting that it sufficiently evaluated the true levels of PM 2.5 within an error range (Wang et al

2018). For counties with more than one monitoring station, the monitor with the highest average
PM2.5 concertation for the day is used as the recorded measurement when averaging daily values
to create a yearly average. The EPA data with both measured and predicted values was chosen to
use in these analyses to further expand the number of counties which could be included in the
regression.
The primary dataset contains the variables used for evaluating the effects of PM 2.5 on all
counties in the U.S. with data for PM 2.5 and lower respiratory mortality rate for each year from
2001 until 2017. A total of 26,100 observations are in this dataset with the observation unit being
a county year. Although all-cause annual mortality is available for all counties within the U.S.,
the analysis of this outcome uses the same 26,100 county/year observations for consistency. For
the analysis of lagged cardiovascular mortality, a total of 22,710 county/year observations had
nonmissing data for all 15 years to form a balanced panel. (The reason for the smaller sample
size is attributed to the higher level of missing values for cardiovascular mortality rates for the
reasons stated earlier.)
Given that the measurement for respiratory mortality was a three-year average, a measure
of PM2.5 was created also using a three-year average to match measurement periods. Moreover, a
one-year lag was incorporated because of the likelihood that the impacts from PM 2.5 exposure
may not be immediate. For example, the mortality rates for 2014, 2015, and 2016 are averaged,
and correspond with the average PM2.5 levels for 2013, 2014, and 2015. Unemployment and
poverty rates for each county and year were included in the regression model to account for their
independent effects on mortality rates and potential correlation with PM 2.5 levels.

To understand the different effects PM 2.5 may have on minority and impoverished
populations, each sample was divided into two even halves around the median county-level
poverty rate of the full sample and divided into two even halves based on the median countylevel percent nonwhite race/ethnicity. Given the possibility that a county’s poverty rate and/or
minority population percentage change over the 15-year period of the study, the mean of each
counties poverty rate and minority population percentage across all years in the sample was
taken and the median of that multi-year average was used to split the sample into the two
subsamples. This analysis allows us to understand whether populations with higher average
poverty rate or minority population face different effects from PM 2.5 exposure.
Given the “panel” nature of the data used in this study (i.e., time-series data for a certain
sample), a two-way fixed effects model was chosen. Using a two-way fixed effects model holds
for the variation due to the change in time (i.e., 0/1 indicators for each year), as well as for
county level fixed effects (i.e., 0/1 indicators for each county) to account for the characteristics
of a county that do not change over time but may influence the level of mortality rates across
counties. Holding for the changes over time is important given the overall decrease in PM 2.5
levels over the period of the study and the overall increase in respiratory mortality rates over the
same period. Without controlling for these independent trends over time, these two general
trends would likely result in regression results showing a negative correlation between PM 2.5 and
mortality rates. The two-way fixed effects model essentially allow the model to be identified by
changes in PM2.5 and mortality over time within counties. The following equation illustrates the
two-way fixed effects model for the first outcome:
lnRespMortRateij = β0 + β1 3yrpm2.5ij-1 + β2 %nwij + β3 %povij + β4 unempij + β5 logpopij + β6 %65 + δi + μj

where lnRespMortRate is the 3-year average of mortality due to chronic lower respiratory
disease per 10,000 people evaluated in percent change (logged). The log of each mortality
classification was used for the main results, while for predicted values the non-logged respiratory
mortality rate was used. The main variable of interest is the coefficient of 3yrpm2.5 which is the
trailing 2 year plus current year average PM 2.5 level for a county i in year j, this variable is lagged
one year to account for the delayed effects of PM 2.5 exposure. Therefore, the assumption is that
the previous year’s PM2.5 exposure influences the current years mortality rate. δ represents
county level fixed effects and μ holds for the effects due to the change in time. The regression
coefficients can be interpreted by first multiplying by 100 to account for interpreting the logged
dependent variable as a percent change from a 1 μg/m3 increase in PM2.5; they are then further
multiplied by 10 to show the effects of a 10 μg/m3 increase in PM2.5, which is the common
interpretation used in previous studies.

Main Results:
The first health effect investigated is the impact of PM 2.5 on chronic lower respiratory
disease mortality rate for all the counties with data available; analyses presented in a later section
stratify by race/ethnicity and income. The full sample has 26,100 county/year observations.
arising from 1,740 counties and 15 years of data. The results, found in Table 1, for this
regression suggest that a one-unit increase or 1 μg/m3 increase in PM2.5 exposure increases
chronic lower respiratory disease mortalities by 0.19% (p<0.1), or alternatively a 10 μg/m3
increase in PM2.5 will result in a 1.9% more mortalities from chronic lower respiratory disease .
As discussed above, the effects of PM2.5 have also been found to lead to increased
mortality rates due to cardiovascular diseases including ischemic heart diseases, cerebrovascular
diseases, and “other” cardiovascular diseases (Ostro et al 2006, Giannadaki et al 2016). Also, as

discussed above, this measure of mortality is observed for a slightly smaller number of counties:
1,510 counties and 22,650 observations at the county year level for the years 2003-2017. The
main regression model (Table 2, Column 1) showed that a 1 μg/m3 increase in PM2.5 resulted in
0.04% more cardiovascular deaths, however, this result was just below the significance level
required for a 90% confidence interval (Table 2 Column 1). Lastly, the effects of PM 2.5 on allcause mortality were investigated using a similar two-way fixed effects regression model using
dataset three which included 1,740 counties and 26,100 observations over the 15-year period
(Table 3 Column 1). Because all-cause mortality rates are measured per 100 people for one
single year, the PM2.5 measure used is also just the one-year level (rather than a three-year
average). The results from the model when using the full data set were insignificant for the PM 2.5
variable.

Comparison to Prior Studies
The results from the two-way fixed-effects models generally align with prior studies of
the effects of PM2.5 on respiratory mortality, while they largely diverge from previous studies for
the effects on cardiovascular mortality and all-cause mortality. The chronic lower respiratory
mortality rate increased by 1.9% when the level of PM 2.5 increased by 10 μg/m3. This result is
largely in line with previous studies examining particulate matter pollution, with Ostro et al.
finding a 10 μg/m3 increase in PM2.5 to be responsible for a 2.2% increase in daily mortality form
respiratory illness (Ostro et al 2006), and Penttinen et al. reporting a 3.96% increase in
respiratory mortality from a 10 μg/m3 increase in PM10 (Penttinen et al 2004). There are
differences that should be recognized, however; while this study evaluated yearly PM 2.5 and
respiratory deaths, the studies by Ostro et al. and Penttinen et al. both used daily PM 2.5 levels and
respiratory mortality. While these short-term effect results help verify the positive correlation

between PM2.5 and respiratory mortality, the results from this study, which lagged PM 2.5 one
year, show that a medium-term health risk also exists, particularly for respiratory illness.
The results for cardiovascular disease mortality were insignificant, which is surprising
considering prior research. Ostro et al. found that a 10 μg/m3 increase in daily PM2.5 resulted in a
0.6% increase in daily cardiovascular mortalities, while a meta-analysis by Vodonos et al. of 53
prior studies looking at long term effects found that a 10 μg/m3 increase in PM2.5 concentrations
was, on average, associated with an 14.6% increase in cardiovascular mortality (Ostro et al 2006,
Vodonos et al 2018). There are a few potential factors which may be attributed to the wide
variation across these results. First, Ostro et al. examined daily PM 2.5 levels and mortality, which
would likely lessen the magnitudes given it does not account for the increased effects due to
persistent exposure. The models reviewed in Vodonos et al. exclusively examined long-term
effects, where one would expect a larger impact on mortality.
The effects on all-cause mortality were found to be below the significance level of p<0.1
and with a negative coefficient. This is inconsistent with Ostro et al.’s estimate of 0.65%. The
insignificant results for cardiovascular and all-cause mortality may have been a result of this
study only measuring county-wide PM 2.5 levels over a three-year period. It is likely the approach
was too broad and not accurately assessing the number of individuals exposed to the county
PM2.5 level (only one monitor per county). This additional spatial variation is likely quite
important, as previous studies have shown the vast variations in PM 2.5 composition and
concentration between locations in a city (Liu et al 2017).
Earlier versions of the regression models did not include a variable for the percent of a
county’s population over age 65, and all returned significant results for the PM 2.5 variable. With
the addition of the percent over 65 variable, only respiratory disease mortality remained

significant. A plausible explanation for this change is that cardiovascular disease and resulting
mortalities are more common in older populations, while respiratory mortality has weaker
relationship with age. All-cause mortality would also be expected to be higher in older
populations. The addition of the percent over 65 likely untangled the effect of age from PM 2.5
and therefore in the mortality classifications with a higher age association (all-cause and
cardiovascular) the significance of the PM 2.5 variable was lost.

Minority Population Analysis
A study by Jbaily et al. found that Black, Asian, and Hispanic populations were exposed
to higher levels of PM2.5, with Black populations experiencing concentrations of PM 2.5 13.7%
higher than white populations in 2016 (Jbaily et al 2022). To evaluate whether this increase in
PM2.5 pollution experienced by Black populations resulted in a larger effect of PM 2.5 on
mortality, each sample was split by whether a county’s average nonwhite population over the 15year period was above or below the median value.
For chronic lower respiratory disease mortality in counties with larger nonwhite
populations, a 10 μg/m3 increase in PM2.5 was found to result in a 3.4% increase in respiratory
mortality, a 72% greater effect than the result for all included counties. Additionally, the PM 2.5
coefficient was insignificant for counties with smaller nonwhite populations, suggesting most
respiratory health effects from PM2.5 are experienced by racial/ethnic minorities. Mortality
resulting from cardiovascular disease in counties with larger nonwhite populations increases by
1.3% for a 10 μg/m3 increase in PM2.5; the full county regression result was insignificant.
Importantly however, counties with a smaller nonwhite population gave a significant negative
coefficient for the PM2.5 variable (Table 2, Columns 3 and 4). PM 2.5 concentration was not found
to have a significant effect on all-cause mortality in larger nonwhite population subsample but

did have a significant negative coefficient for the smaller nonwhite population subset. These
results suggest that higher nonwhite populations do see increased health risks from PM 2.5
exposure.
While the results from the regression do suggest there is a significantly higher impact on
populations with a larger nonwhite population, it is uncertain whether these effects are due to
increased PM2.5 exposure. Descriptive analysis of the subsamples show that PM 2.5 levels are 0.2
μg/m3 lower on average in populations with a larger nonwhite population, but mortality rates for
all three categories are higher. The data also shows larger nonwhite populations are much likely
to be in population centers, with an average population size of 260,000 compared to 69,000 in
the smaller nonwhite population subsample. This implies there may be a difference in pollution
sources between the two datasets, with the minority populations experiencing urban pollution
such as traffic, and industrial activities. Prior studies have found that particulate matter has
different compositions in rural and urban setting due to different emission sources (Valavanidis
et al 2008, Viana et al. 2008). Furthermore, the percent of individuals exposed to sources of
PM2.5 may be higher in more populated counties with more individuals per square mile leading to
a greater number of individuals with negative health effects (Yu et al. 2020). The poverty rate is
2% higher in the larger nonwhite population counties, which may suggest individuals in these
populations have greater difficulty accessing medical care. Another factor which may be
affecting the results is the number of PM 2.5 observations which are modeled is 20% higher in the
smaller nonwhite population subsample; however, previous research has shown the modeled
PM2.5 values to be highly accurate (Wang et al 2018). The data were also split at the median of
each county’s average minority population over the 15-year sample period, which may cover up
meaningful changes in the minority demographic of individual counties and therefore mute

potential effects. Further studies are needed to understand the exact cause for the increased
effects of PM2.5 on mortality in higher minority populations, however, the results suggest that
minority populations do face greater health consequences in terms of mortality due to PM 2.5
exposure.

Effects of Poverty on Mortality from PM2.5
The study by Jbaily et al. also investigated the difference in PM 2.5 exposure across
income groups and found only slightly higher PM2.5 levels in low-income areas (Jbaily et al
2022). However, despite a minimal difference in PM 2.5 exposure, there may still be meaningful
differences in health outcomes between low-poverty and high-poverty areas. To analyze the
potential difference in health outcomes the same method was used as with the racial/ethnic
minority population subsets to create two balanced panels, one with above-median average
entire-period poverty rates and the other with below-median average entire-period poverty rates.
For higher-poverty counties, a 10 μg/m3 increase in PM2.5 resulted in a 2.6% increase in mortality
from chronic respiratory illness (P<0.1, Table 1, Column 2). This represents a 32% greater effect
on respiratory mortality rate in higher-poverty counties in comparison with all counties. For
mortality due to cardiovascular diseases, a 10 μg/m3 increase in PM2.5 results in a 2.4% increase
in the mortality rate, while the effect on all counties was insignificant. The regression for allcause mortality in high-poverty counties indicates that a 10 μg/m3 increase in PM2.5 raises the allcause mortality rate by 1.3% , while the main regression was insignificant. For all three mortality
categories, there were no significant positive associations with PM 2.5 in lower-poverty counties.

These results suggest that impoverished populations and counties face greater mortality risks
from PM2.5 exposure.
A multitude of factors may cause the increased effect of PM 2.5 on mortality for
impoverished populations. The descriptive analysis indicates that the higher-poverty counties
have a slightly higher percentage of the population over 65, fewer physicians per capita, and a
smaller population size. The older population in these counties may increase the effect of PM 2.5
on mortality as older individuals are generally more susceptible to severe illness. Fewer
physicians per capita suggest that it may be harder for individuals in these populations to receive
the medical services needed to prevent mortality from PM 2.5 exposure. Furthermore, it is likely
harder for people in poverty to obtain medical care. This difficulty to afford medical care may be
exacerbated when already located in counties with few physicians and result in more negative
health outcomes. Higher-poverty counties have an average PM 2.5 concentration 0.24 μg/m3
higher than low-poverty counties while also facing higher mortality rates for all three measures.
It is possible that increased exposure to PM 2.5, combined with a diminished ability to receive
medical care, is responsible for the increased effect of PM 2.5 on mortality rates in higher-poverty
populations. Further studies should be completed on a more detailed scale to further understand
how those in poverty face an increased health risks from PM 2.5 exposure.

Predicted Values
To evaluate the health cost of PM2.5 exposure in monetary terms, the statistical value of
life (SVL) was applied to the predicted mortality rates from the regression results for varying
levels of PM2.5. The SVL can be calculated by surveying individuals what they would pay to
reduce their chances of dying that year or by empirically estimating wage differentials associated
with occupations with varying fatality risk. The SVL in 2020 of $11.8 million USD will be used
to measure the health cost or savings resulting from PM 2.5 exposure(Putnam J 2021). The
respiratory mortality rate model will be used to analyze the yearly cost of PM 2.5 given it was the
only model with significant results for the full dataset. While this will not provide a holistic
understanding of the overall cost of PM 2.5 in the U.S. for all deaths, it will highlight the
detrimental effects of PM2.5 for one important type of death. Table 6 shows predicted values for
deaths and health cost from respiratory illness at different percentiles of PM 2.5 concentration. The
models predicted deaths at the 25th and 75th percentile of PM2.5 levels to be 6.33 and 6.41 per
10,000 people, respectively. When extrapolated to the entire population this translates into 1,959
additional deaths from respiratory disease annually in the U.S. from PM 2.5 increasing from 8.7
μg/m3 to 11.7 μg/m3. The mean PM2.5 concentration in the U.S. decreased from 11.92 μg/m3 in
2003 to 8.37 μg/m3 in 2017. The predicted values for respiratory disease from the model for
these concentrations of PM2.5 suggest that 4,014 deaths were avoided in 2017 due to the

cumulative reductions in PM2.5 pollution from 2000 to 2017. Applying the SVL to this estimate
indicates savings of over $44.96 billion (Table 7).
Further predicted values for additional deaths and cost were calculated by applying
different worldwide yearly regulatory standards for PM 2.5 concentration to the regression model
(Figure 8). The standards used were the current European Union standard of 20 μg/m3, the
former U.S. standard of 15 μg/m3, the current U.S. standard of 12 μg/m3 and the WHO standard
of 10 μg/m3 (Figure 8). The regression model estimates indicate that a change from the E.U.
standard to the current U.S standard would prevent 9,088 deaths from respiratory disease
annually with a cost saving of nearly $45 billion. Furthermore, the U.S. changed its regulatory
standard for PM2.5 from 15 μg/m3 to 12 μg/m3 in 2013. Applying these two levels to the model,
assuming these are the exact concentrations of PM 2.5 in the atmosphere, indicates that this policy
change would eliminate 1,934 deaths from lower respiratory illness yearly at a cost saving of
$21.6 billion dollars. These results show that the EPA’s regulatory measures had positive health
and economic benefits and that stronger policy restrictions on PM 2.5 emission would yield
additional benefits. Lastly, mortality values were predicted for PM 2.5 at 0 μg/m3 and the 2011
level of 9.712 μg/m3 to assess how many deaths in a year are the result of PM 2.5 pollution. The
results indicate that PM2.5 was responsible for 9,480 deaths. While this value is much lower than
prior studies, it is an estimate for chronic lower respiratory illness alone, which makes up a small
portion of overall mortality. A prior study by Goodkind et al. estimated 107,000 premature

deaths in 2011 within the U.S. (Goodkind et al 2019). The differences mainly arise from this
current study’s focus on respiratory mortality when calculating predicted values. Additionally,
Goodkind et al. used an Intervention Model for Air Pollution which allowed for source location
estimates for PM2.5 pollution with varying grid sizes (that were smaller for cities and larger for
rural areas) to capture fine scale exposure to PM 2.5. This detailed model allows for a more
specific estimate of health effects than the county-level model employed in this study can
evaluate, resulting in a likely loss of association between PM 2.5 and mortality. Despite these
limitations, the results still strongly support the findings of previous studies that PM 2.5 emission
pose a significant health and economic cost on society.

Limitations:
The methods employed in this study had various strengths, including over 15 years of
observations, a relatively high number of counties with available data, and a two-way fixed
effects regression model to account for unmeasured, time-invariant county characteristics to
better identify PM2.5’s causal effect on mortality. Additionally, the large number of counties in
the model allowed for further sub-population analysis without losing much statistical power,
providing new evidence for how PM2.5 effects impoverished and minority populations to a
greater extent.
However, there are several limitations which may have impacted the results. Given the
variabilities of PM2.5 concentration based on proximity to sources and atmospheric conditions, in
addition to the variation in the particles constituting PM 2.5 between sources, it is likely many
effects were not measured. The PM2.5 data from the EPA used a large number of predicted

values, thus decreasing their reliability, but also did not distinguish the substances making up the
PM2.5 measure, thereby limiting the ability to understand location-specific effects of PM 2.5, such
as urban versus rural differences. It is reasonable to question whether a two-way fixed-effects
model at the county level was the proper model to evaluate PM 2.5 emissions’ effect on mortality.
The use of linear regression models is not unprecedented in the estimating the health effects of
PM2.5, with Li et al. using a similar model to evaluate perinatal mortality in China with county
level data from 2002 to 2015, and with Correia et al. using a similar model to investigate PM 2.5’s
effect on life expectancy in the U.S. (Li et al 2021, Correia et al 2013). However, most models
for the effects of PM2.5 use more advanced methods to account for spatial variation, various
pollutant sources, composition differences, and primary and secondary sources. Additionally, the
regression models were limited by the availability of data at the county level for various
demographic characteristics, especially for smaller counties. To maintain a larger sample size, a
strength of this study, not all potentially relevant variables were included in the regression, which
may partially explain the relatively low R-squared values for the regressions. These limitations
likely were the cause of insignificant results when evaluating PM 2.5’s effects on all-cause and
cardiovascular mortality using the entire sample. Both of these variables have a higher incidence
rate than respiratory mortality, which suggest there are a multitude of other factors associated
with them, hence diluting PM2.5’s effect on their respective mortality rates. Additionally, the use
of a model which captures spatial distribution at a “fine grain” scale may be better suited to
isolate PM2.5’s effect of cardiovascular and all-cause mortality. This possibility is further
highlighted by the regressions ran on high-poverty and minority populations which were still
able to provide significant results, suggesting the model could pick up the larger effects on these
populations, which are known to be more at risk, but not the counties including low-poverty

and/or largely white populations. Lastly, there are various health cost that are not included in the
study due to data limitations. This study did also not investigate the effect of PM 2.5 emissions on
health spending or life expectancy, both of which are relevant in measuring the health cost of
PM2.5 pollution. Despite these limitations, this study contributes and expands upon the existing
literature by further supporting the previously found association between PM 2.5 and respiratory,
cardiovascular, and all-cause mortality, as well as revealing the increased mortality risks
minority and impoverished populations face from PM 2.5.

Conclusion
The impacts of climate change have become a focus of social and political conversations.
PM2.5 is one small aspect of climate change but one that can have drastic effects on health
outcomes. PM2.5 and particulate matter pollution have research value, as the health effects are not
distance predictions, and there are visible indicators to show progress, such as a reduction in
smog. The visible nature and real time effects present researchers with an opportunity to
highlight to the real impacts humans have on their environment and health while providing
strong empirical evidence which can be used to further progress climate change policy. Using
panel data and a two-way fixed effects model with county level data from 2003 to 2017, this
study was able to provide further evidence that PM2.5 does have significant negative effects on
health outcomes, and furthermore highlights the progress already made in reducing its
consequences of human health and justifies the use of more stringent PM 2.5 regulation to further
reduce mortality.
The main findings of this study are that a 10 μg/m3 increase in PM2.5 concentration can
increase mortality due to chronic lower respiratory illness by 1.9%, with the effects on larger
nonwhite counties 72% greater and on higher-poverty counties 32% greater. A 10 μg/m3 increase

in PM2.5 concentration was found to result in a 2.4% increase in cardiovascular disease mortality
in higher-poverty counties and 1.2% in higher nonwhite counties. For all-cause mortality, a 10
μg/m3 increase in PM2.5 was found to increase mortality in higher-poverty rate counties by 1.3%.
Lastly, these estimates suggest that the U.S. reduced the number of deaths from lower respiratory
disease by 4,000 and saved $44 billion in 2017 because of the decline in PM 2.5 levels between
2003 and 2017. Moreover, the more stringent regulations implemented in 2013 have the potential
to reduce the number of deaths from respiratory disease per year by over 1,900 and reduce
economic costs by $21.5 billion. Despite some limitations of the model design and “fine grain”
data availability, the results are still consistent with the findings of other studies regarding the
health impact that PM2.5 has both in terms of mortality and economic cost. It also expands upon
previous studies by revealing the larger effects for minority and impoverished counties. Most
importantly, the results found here help validate the policy efforts made to reduce PM 2.5
emissions by showing the positive effects resulting from the U.S.’s decreasing PM 2.5 level and by
providing strong evidence that stricter regulations on PM 2.5 levels will have positive economic
and health effects; both are results which should further motivate meaningful policy action to
address the effects of climate change and global warming.

Table 1: Respiratory Mortality Regression Results

Table 2: Cardiovascular Mortality Regression Results

Table 3: All-Cause Mortality Results

Table 4: Descriptive Analysis
Variable
PM2.5(10 μg/m3)
2003
2017
Reduction
Resp. Mort.(per. 10K)
2003
2017
Change
Cardio Mort (per.10k)
2003
2017
Reduction
All-Cause Mort (Per. 10k)
2003
2017
Change
Population(hundred of thousands)
2003
2017
Change
Prop 65+ (%)
2003
2017
Change
Prop Non-White (%)
2003
2017
Change
Prop in Poverty(%)
2003
2017
Change

Mean

SD

11.93
8.37
3.56

(2.4)
(1.52)

5.5
7.16
1.66

(1.88)
(2.92)

35.06
31.53
3.53

(9.73)
(8.89)

97.7
102.4
4.7

(23.3)
(23.6)

1.57
1.77
.2

(3.94)
(4.33)

13.77
17.82
4.05

(3.45)
(4.18)

18.54
23.45
4.91

(16.80)
(18.14)

12.81
14.83
2.02

(4.45)
(5.45)

Table 5. Sub Population Descriptive Analysis
Avg. Non-White Pop.
Below Median

Avg. Non-White Pop.
Above Median

PM25 Level

10.34 (2.33)

10.15(2.4)

10.12 (2.43)

10.36 (2.3)

All-Cause Mortality (Per 10k)

102.7 (21.3)

91.6(23.3)

89.1 (20.8)

105.2 (22.2)

Lower Respiratory Mort. (Per 10K)

6.69 (2.33)

5.57 (2.3)

5.47 (1.89)

7.03 (2.7 )

Cardiovascular Mortality (Per 10k)

33.73( 8.6)

29.7(9.2)

28.65 (8.13)

34.4 (9.0)

Population(hundreds of thousands)

0.69 (0.75)

2.6 (4.3)

1.91 (3.4)

1.43(4.7)

Prop. 65+

16.4 (3.7)

14.2 (3.9)

15.1 (4.2)

15.6 (3.7)

Physicians Per 1,000 Capita

1.24 (.99)

1.78 (1.6)

1.64 (1.4)

1.38 (1.3)

Prop. Non White

7.87 (3.93)

34.3 (14.7)

16.38 (13.1)

25.82 (19.89)

Poverty Rate

14.16 (5.11)

16.47 (5.9)

11.21 (2.9)

19.43 (4.5)

81%

61%

69%

73%

County Statistics

% Modeled PM2.5

Avg. Poverty Rate Avg. Poverty Rate
Below Median
Above Median

Table 6: U.S. PM2.5 Percentile Predicted Costs
PM2.5
Percentile
10th
25th
50th
75th
90th

PM2.5
Concentration
7.40
8.96
10.00
11.70
13.50

Predicted
Deaths Per
10,000
6.29
6.33
6.36
6.41
6.46

Deaths per Avg.
County Size
(167,099)
105.05
105.71
106.35
107.19
107.99

Yearly Predicted
Deaths in U.S.

Additional
Deaths

Additional
Health Cost
(Millions $)

246,759.26
248,298.99
249,816.08
251,774.62
253,664.90

1,539.74
1,517.09
1,958.54
1,890.28

17,245.07
16,991.42
21,935.60
21,171.14

Table 7: Predicted Costs at Various Regulatory Levels

PM2.5 Standard

Yearly Nation Wide
Predicted Deaths

Change in Yearly
Mortality

Additional Cost Savings
(Millions $)

Old E.U. (20)

260,829.60

Old U.S. (15)

253,665.37

(7,164.22)

$80,239.31

New U.S. (12)

251,740.71

(1,924.66)

$21,556.23

W.H.O (10)

249,476.93

(2,263.78)

$25,354.37

Table 8: Cost Savings in 2017 due to PM2.5 Reduction (2003-2017)

U.S PM2.5 Level

Yearly Nation-Wide
Predicted Deaths

2003 (11.92)

251,650.16

2017 (8.374)

247,635.55

Change in Yearly
Mortality

Cost Savings (Millions $)

(4,014.61)

$44,963.61

Table 9: Yearly Cost of Respiratory Illness due to PM2.5 (2017)

U.S PM2.5 Level
Zero PM2.5
Emissions
2017 Emissions
Levels (8.374)

Yearly Nation-Wide
Predicted Deaths

Change in Yearly
Mortality

Additional Costs (Millions $)

9,480.64

$106,183.18

238,154.91
247,635.55
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